ArticleHaematologica2025

Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma.

Ingrid Quist-Lokken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.